Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Richard Ziehr, M.D.

Concepts (133)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Respiration, Artificial3202127260.650 Why?
Coronavirus Infections3202031150.610 Why?
Pulmonary Gas Exchange120203890.610 Why?
Pneumonia, Viral3202032380.610 Why?
Respiratory Mechanics120207210.520 Why?
Prostatic Neoplasms152015111010.510 Why?
Pandemics3202087480.390 Why?
Respiratory Insufficiency1202012400.380 Why?
Physical Phenomena12010480.350 Why?
Ribosomes120104970.270 Why?
Antineoplastic Agents, Hormonal1201415360.260 Why?
Income1201418780.250 Why?
Androgen Antagonists1201414120.250 Why?
Molecular Chaperones120107620.250 Why?
SEER Program7201514440.200 Why?
Healthcare Disparities5201434150.190 Why?
Nitric Oxide Synthase Type III120247060.190 Why?
Coronary Disease1201459190.170 Why?
Exercise Tolerance120248460.160 Why?
Prone Position120202030.160 Why?
Prostatectomy3201517860.150 Why?
Renal Replacement Therapy120202820.150 Why?
Proto-Oncogene Proteins c-myc120239980.150 Why?
Patient Positioning120203320.140 Why?
Administration, Inhalation1202011690.140 Why?
Brachytherapy2201512200.140 Why?
Reference Standards1202010140.140 Why?
Vasoconstrictor Agents120206560.130 Why?
Lactic Acid1202111400.130 Why?
Fluid Therapy120205870.130 Why?
Vasodilator Agents120209900.130 Why?
Positive-Pressure Respiration120207130.120 Why?
Renal Insufficiency120208120.120 Why?
Goserelin120141260.110 Why?
Vascular Endothelial Growth Factor Receptor-2120165470.110 Why?
Anilides120164130.110 Why?
Leuprolide120143130.100 Why?
Insurance Coverage2201419460.100 Why?
Proto-Oncogene Proteins c-met120165640.100 Why?
Intubation, Intratracheal1202013590.100 Why?
Health Status Disparities2201418850.100 Why?
Organs at Risk120143670.100 Why?
Intensive Care Units2202138000.090 Why?
Prostate-Specific Antigen3201524630.090 Why?
Hydroxylamine12010170.090 Why?
Puromycin12010410.090 Why?
Sodium Hydroxide12010370.090 Why?
Ultracentrifugation120101820.090 Why?
Fluorescence Polarization120101390.080 Why?
Lung Diseases1202019440.080 Why?
Edetic Acid120102780.080 Why?
Ribonuclease, Pancreatic120101120.080 Why?
Diabetes Mellitus2202058890.080 Why?
Rectum120149000.080 Why?
Middle Aged1720242234920.080 Why?
Extracorporeal Membrane Oxygenation1202014830.080 Why?
Aged1620211715040.080 Why?
Metformin120159090.070 Why?
Salvage Therapy1201412730.070 Why?
Adenocarcinoma2201563950.070 Why?
Hospital Mortality1202153490.070 Why?
Sepsis1202126080.070 Why?
Aged, 80 and over62020596290.070 Why?
Neoplasms, Second Primary1201510610.070 Why?
Prostate1201517650.070 Why?
Geriatric Assessment1201414220.070 Why?
Protein Folding120108710.070 Why?
Male1920213647190.060 Why?
Humans2420247681660.060 Why?
Comorbidity12020105900.060 Why?
Cohort Studies22020417540.060 Why?
Pyridines1201628940.060 Why?
Risk Factors92021749440.060 Why?
Severity of Illness Index12021159480.050 Why?
Smoking1202090920.050 Why?
Procollagen-Proline Dioxygenase12023810.050 Why?
Escherichia coli Proteins1201010580.050 Why?
Body Mass Index12021130530.050 Why?
United States92021730390.050 Why?
Protein Biosynthesis1201020940.050 Why?
Retrospective Studies62021817620.050 Why?
Insurance, Health1201425170.050 Why?
Cell Hypoxia120236620.050 Why?
Hypertension1202086160.040 Why?
Signal Transduction12023236450.040 Why?
Mutation12024302380.040 Why?
Logistic Models12014132900.040 Why?
Hypoxia-Inducible Factor 1, alpha Subunit120236270.040 Why?
Obesity12021130900.040 Why?
Critical Illness2202127560.040 Why?
Adult720242236460.030 Why?
Vascular Endothelial Growth Factor D12016610.030 Why?
Socioeconomic Factors3201578520.030 Why?
Risk Assessment22015243150.030 Why?
Young Adult22020600660.030 Why?
Neoplasm Recurrence, Local1201494190.030 Why?
Massachusetts2202188900.030 Why?
Europe1202134360.030 Why?
Androgen Receptor Antagonists120151230.030 Why?
Survival Rate22021128400.030 Why?
Patient Protection and Affordable Care Act2201411880.030 Why?
Age Factors32015184120.030 Why?
Minority Health12014790.030 Why?
Diagnosis-Related Groups120154450.030 Why?
Marital Status120154260.030 Why?
Risk2201596130.030 Why?
Female620243971920.030 Why?
Postoperative Complications12014158320.020 Why?
Incidence32015215380.020 Why?
Epidemiologic Methods1201513280.020 Why?
Biopsy, Needle1201516220.020 Why?
Age of Onset1201533470.020 Why?
Magnetic Resonance Imaging12015367430.020 Why?
Radiotherapy Dosage1201429160.020 Why?
Disease-Free Survival1201668470.020 Why?
Kaplan-Meier Estimate1201665260.020 Why?
Neoplasm Metastasis1201649120.020 Why?
Neoplasms12014223710.020 Why?
Molecular Targeted Therapy1201628300.020 Why?
Lung12023100990.010 Why?
Population Surveillance1201425960.010 Why?
Feasibility Studies1201453150.010 Why?
Follow-Up Studies22015393480.010 Why?
Mortality1201429110.010 Why?
Survival Analysis12014101010.010 Why?
Hospitalization12021108400.010 Why?
Prognosis12021300100.010 Why?
Neoplasm Staging12015112440.010 Why?
Protein Kinase Inhibitors1201657030.010 Why?
Databases, Factual1201580800.010 Why?
Predictive Value of Tests12015154540.010 Why?
Quality of Life12014134900.010 Why?
Treatment Outcome12014653710.000 Why?
Ziehr's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (133)
Explore
_
Co-Authors (55)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.